Welcome to our dedicated page for Medical Properties Trust news (Ticker: MPT), a resource for investors and traders seeking the latest updates and insights on Medical Properties Trust stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Medical Properties Trust's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Medical Properties Trust's position in the market.
MPT (NYSE:MPT) announced that its board declared a regular quarterly cash dividend of $0.09 per common share, payable on October 8, 2026 to shareholders of record as of September 10, 2026. The company is a global hospital-focused real estate investment trust.
Medical Properties Trust (NYSE:MPT) reported second quarter 2026 results and announced a major refinancing. Net loss attributable to common stockholders was approximately $3 million or ($0.01) per share, versus a $98 million loss or ($0.16) per share a year earlier. Normalized FFO rose to $92 million ($0.15 per share) from $81 million ($0.14 per share), with total revenues increasing to $259.3 million from $240.4 million.
MPT announced a privately negotiated $2.4 billion secured notes refinancing, including about $123 million discount, to repay 2026 notes and roughly half of 2027 notes, reducing debt maturing through 2028. The company agreed to asset sales expected to generate about $172 million in Q3 cash and received $100 million from the Infracore IPO, with another $35 million expected later in Q3. MPT also restructured leases with Lifepoint and Scion, reducing Scion exposure to one facility, and paid a $0.09 per share dividend in July 2026.
Medical Properties Trust (NYSE: MPT) agreed to a $2.4 billion private refinancing in which its operating partnership and MPT Finance will issue new 9.25% Senior Secured Notes due 2032 to certain institutional investors via a new-money private placement and private exchange.
According to the company, cash proceeds will fully redeem senior notes due 2026 and partially redeem 2027 notes, while about $1.5 billion of 2027–2031 unsecured notes will be exchanged. Upon closing, total principal debt is expected to decline by approximately $123 million to about $9.5 billion, with unsecured note maturities through 2028 reduced to roughly $1.3 billion. Interest on the new Notes will be paid semi-annually starting December 15, 2026, with maturity on February 15, 2032 and various optional redemption features.
MPT (NYSE: MPT) will host a conference call and webcast on Monday, August 10, 2026 at 11:00 a.m. Eastern Time to discuss its second quarter 2026 financial results. The earnings press release will be issued before the market opens that day.
Investors can join via phone at 833-461-5787 (toll-free) or 585-542-9983 using Meeting ID 594327200, or listen through a live webcast on the Investor Relations section of www.mpt.com. A webcast replay will be available for one year after the call.
Medical Properties Trust (NYSE:MPT) announced that Infracore SA, its Swiss hospital real estate affiliate, is expected to list on the SIX Swiss Exchange at CHF 54 per share, implying an equity market cap of CHF 826 million, about 5% above MPT’s carrying value.
Infracore plans to issue 3.7 million new shares for roughly CHF 200 million. MPT expects about $150 million in aggregate cash from share sales and loan/dividend repayments, and its stake is projected to fall from 70% to about 47–49.9%.
MPT (NYSE:MPT) announced that its Board of Directors declared a regular quarterly cash dividend of $0.09 per share on common stock.
The dividend is payable on July 16, 2026 to stockholders of record as of June 18, 2026.
Medical Properties Trust (NYSE: MPT) reported Q1 2026 results: net income $33M ($0.05/share) and NFFO $82M ($0.14/share). Portfolio totals approximately $15B of assets across 378 properties. Sold two facilities for ~$31M, acquired a European post-acute facility for €23M, and increased HSA contractual rent to 75% of stabilized rent. The company paid a quarterly dividend of $0.09 per share and scheduled an investor webcast on April 30, 2026.
MPT (NYSE:MPT) will host a first quarter 2026 financial results conference call and webcast on Thursday, April 30, 2026 at 11:00 a.m. ET. A press release with first quarter 2026 results will be issued before market open on April 30, 2026.
Dial-in numbers: 800-715-9871 (U.S. & Canada) and 646-307-1963 (International) with passcode 4201784. The call will be webcast on the Investor Relations section of www.mpt.com. Telephone replay available through May 7, 2026; webcast replay available for one year.
Medical Properties Trust (NYSE: MPT) issued a statement on March 10, 2026 regarding Healthcare Systems of America (HSA). The company said HSA is fully current on rent and that MPT does not expect the unrelated litigation involving HSA principals to affect rent collections.
MPT noted it sent ordinary course legal notices to protect its interests and reiterated that HSA is working on revenue cycle improvements, cash collections, and restoring clinical volumes; MPT continues to monitor operating trends and is encouraged by progress.
Medical Properties Trust (NYSE: MPT) reported fourth-quarter and full-year 2025 results on February 19, 2026. Q4 net income was $0.03 per share and Q4 NFFO was $0.18 per share; full-year 2025 net loss was ($0.46) per share with NFFO $0.58 per share.
Portfolio totals approximately $15 billion in assets across 384 properties and ~39,000 licensed beds. Key events include a lease ramp to $45 million annual rent (Dec 2026), a 20-year Vibra restructuring with an $18 million one-time payment, two acquisitions (~$32M and ~€23M), $23.4M of share repurchases and a $0.09 quarterly dividend.